← Back to headlines
AbbVie a new outperform at RBC Capital Markets on durable growth
RBC Capital Markets has upgraded its rating for pharmaceutical company AbbVie to 'outperform,' citing expectations for durable growth.
25 Feb, 16:59 — 25 Feb, 16:59
Sources
Showing 1 of 1 sources
